Cardio Diagnostics Holdings, Inc. (CDIO) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

Cardio Diagnostics Holdings, Inc.

CDIO

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

20M

Biotechnology

Next Earning date - 21 May 2025

20M

Biotechnology

Next Earning date - 21 May 2025

0.39USD

0.02 ( 4.22%)

Market Closed (as of Apr 17, 20:00 EDT)

Relative Strenght

Volume Buzz

-89%

Earning Acce

Dist 52w H.

78%

Overview Chart

Quote Panel

Updated April 18, 2025

1W 0.36 % 1M -15.79 % 3M -35.87 % 1Y -55.18 %

Key Metrics

Market Cap
20.33M
Shares Outstanding
52.15M
Share in Float
48.21M
Dividende
0

Earning Date
21 May 2025
Price Target
0.3899
Average Volume
2.21M
Beta
3.679

Range
0.19-1.77
Industry
Biotechnology
Website
https://cardiodiagnosticsinc.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

559.12x

P/S Ratio

0.96x

P/B Ratio

0.1

Debt/Equity

-24028.2%

Net Margin

$-0.3

EPS

How CDIO compares to sector?

P/E Ratio

Fundamentals

Relative Strength

CDIO

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

CDIO

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$525K

11536%

2025-Revenue

$0.23

-270%

2025-EPS

$315K

78%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q1.23

N/A

-0.11
vs -0.03

Q2.23

N/A

-0.39
vs -0.09

Q3.23

N/A

-0.16
vs 0.02

Q4.23

N/A

-0.07
vs -0.25

Q1.24

N/A

-0.20
vs -0.11

Q2.24

N/A

-0.06
vs -0.39

Q3.24

N/A

-0.06
vs -0.16

Q4.24

N/A

-0.01
vs -0.07

Q1.25

N/A

-0.06
vs -0.20

Q2.25

N/A

-0.06
vs -0.06

Sales Growth

YoY

Current

Estimates

Q1.23

NA vs NA

Q2.23

1.7K vs NA

Q3.23

10K vs NA

Q4.23

+459%

5.3K vs 950

Q1.24

15.9K vs NA

Q2.24

+356%

7.9K vs 1.7K

Q3.24

-34%

6.6K vs 10K

Q4.24

-15%

4.5K vs 5.3K

Q1.25

+214%

50K vs 15.9K

Q2.25

+853%

75K vs 7.9K

Return on Equity

QoQ

Q1.23

-30%

-0.30
vs -0.55

Q2.23

-138%

-1.38
vs -0.30

Q3.23

-84%

-0.84
vs -1.38

Q4.23

-47%

-0.47
vs -0.84

Q1.24

-137%

-1.37
vs -0.47

Q2.24

-42%

-0.42
vs -1.37

Q3.24

-38%

-0.38
vs -0.42

Q4.24

-16%

-0.16
vs -0.38

Institutionnal Ownership

Earnings Growth

Latest News

businesswire.com

8 hours ago

Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology's 74th Annual Scientific Session

businesswire.com

8 hours ago

Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations

businesswire.com

8 hours ago

Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

businesswire.com

8 hours ago

Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

businesswire.com

8 hours ago

Cardio Diagnostics Announces It's Exhibiting at the 2024 Onsite Employee Health Clinics Forum

businesswire.com

8 hours ago

Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality